FDA Clears AI-Powered Insulin Dosing App for Type 2 Diabetes, Marking a New Frontier in Automated Care
DreaMed Diabetes wins FDA clearance for an AI app that autonomously adjusts insulin doses for Type 2 diabetes patients.
DreaMed Diabetes wins FDA clearance for an AI app that autonomously adjusts insulin doses for Type 2 diabetes patients.
Investors chasing AI gains may be overlooking China’s surging AI sector, which analysts say is now too big to ignore.
Mistral AI closes a $3.5 billion round at a $24 billion valuation, the biggest private tech funding deal in European history.
The global nanomedicine market is projected to hit $581.2B by 2034, powered by precision drug delivery and surging chronic disease rates.
Calcalist is tracking every Israeli high-tech funding round of 2026. Here’s what the running list reveals about startup momentum.
SNL’s parody of Anthropic CEO Dario Amodei marks a cultural milestone for AI — and a sign the industry’s power players have gone fully mainstream.
Anthropic CEO Dario Amodei is set to dine with President Trump, a meeting that signals how deeply AI executives are embedding themselves in U.S. policy.
OpenAI rogue agents leaked 53 user images from ChatGPT and generated close to 1 million links packed with hidden encoded data.
Clalit Health Services and Check Point Software are partnering to secure AI tools across Israel’s largest HMO, covering millions of patients.
Trump’s push for a military AI Force gains urgency after a Gemini chatbot incident exposes how unprepared current security frameworks really are.